History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment response
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment response
Authors
Keywords
Breast cancer, Oral contraceptives, Tumor characteristics, Prognosis, Treatment prediction, Endocrine therapy
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 149, Issue 2, Pages 505-515
Publisher
Springer Nature
Online
2015-01-04
DOI
10.1007/s10549-014-3252-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmö Diet and Cancer Cohort
- (2014) Karin Elebro et al. CANCER CAUSES & CONTROL
- Oral Contraceptives and Breast Cancer Risk Overall and by Molecular Subtype Among Young Women
- (2014) E. F. Beaber et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Impact ofCOX2genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients
- (2014) Andrea Markkula et al. INTERNATIONAL JOURNAL OF CANCER
- Pre- and postoperative alcohol consumption in breast cancer patients: impact on early events
- (2014) Maria Simonsson et al. SpringerPlus
- Postmenopausal breast cancer, androgens, and aromatase inhibitors
- (2013) C. Campagnoli et al. BREAST CANCER RESEARCH AND TREATMENT
- Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women’s Health Initiative Observational Study
- (2013) Rowan T. Chlebowski et al. JNCI-Journal of the National Cancer Institute
- Association between common risk factors and molecular subtypes in breast cancer patients
- (2012) Fatma P. Turkoz et al. BREAST
- Clinical Profiles Predict Early Nonadherence to Adjuvant Endocrine Treatment in a Prospective Breast Cancer Cohort
- (2012) A. Markkula et al. Cancer Prevention Research
- Breast cancer after hormone replacement therapy – does prognosis differ in perimenopausal and postmenopausal women?
- (2011) A.K. Baumgärtner et al. BREAST
- Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients
- (2011) K B Lundin et al. BRITISH JOURNAL OF CANCER
- Oral Contraceptive Use and Survival in Women with Invasive Breast Cancer
- (2011) Y. Lu et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Dual IGF-1R/InsR Inhibitor BMS-754807 Synergizes with Hormonal Agents in Treatment of Estrogen-Dependent Breast Cancer
- (2011) X. Hou et al. CANCER RESEARCH
- Reproductive History and Oral Contraceptive Use in Relation to Risk of Triple-Negative Breast Cancer
- (2011) A. I. Phipps et al. JNCI-Journal of the National Cancer Institute
- Androgens and breast cancer
- (2011) Joanne Kotsopoulos et al. STEROIDS
- Use of Four Biomarkers to Evaluate the Risk of Breast Cancer Subtypes in the Women's Contraceptive and Reproductive Experiences Study
- (2010) H. Ma et al. CANCER RESEARCH
- Risk Factors for Triple-Negative Breast Cancer in Women Under the Age of 45 Years
- (2009) J. M. Dolle et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Recent Decline in Age at Breast Development: The Copenhagen Puberty Study
- (2009) L. Aksglaede et al. PEDIATRICS
- Coffee Consumption and CYP1A2*1F Genotype Modify Age at Breast Cancer Diagnosis and Estrogen Receptor Status
- (2008) E. Bageman et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now